Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease
β Scribed by Makoto Tanaka; Chihiro Namiki; Dinh Ha Duy Thuy; Hidefumi Yoshida; Keiichi Kawasaki; Kazuo Hashikawa; Hidenao Fukuyama; Toru Kita
- Book ID
- 119301492
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 381 KB
- Volume
- 225
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To determine whether donepezil treatment (10 mg/day over 24 weeks) is associated with delayed emergence of apathy in patients with mild to moderate Alzheimer's disease (AD) and to explore relationships between donepezil's effects on apathy and other Neuropsychiatric Inventory (NPI)measured behaviour
## Abstract ## Background Donepezil is a drug used for treatment in patients with Alzheimer's disease (AD). Information regarding the costβeffectiveness of this medication was previously rare in Asia. We used techniques of decision analysis and economic evaluation in conjunction with available loc